Patent 7420053 was granted and assigned to Shionogi on September, 2008 by the United States Patent and Trademark Office.
The present invention relates to 2-imino-1,3-thiazine derivatives, in specific, 2-imino-1,3-thiazine derivatives having a selective antagonistic activity or agonistic activity to a cannabinoid type 2 receptor and their pharmaceutical use.